![Christy Oliger](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Christy Oliger
Direttore/Membro del Consiglio presso KARYOPHARM THERAPEUTICS INC.
Patrimonio netto: 108 070 $ in data 30/06/2024
Posizioni attive di Christy Oliger
Società | Posizione | Inizio | Fine |
---|---|---|---|
KARYOPHARM THERAPEUTICS INC. | Direttore/Membro del Consiglio | 28/08/2020 | - |
Independent Dir/Board Member | 28/08/2020 | - | |
REPLIMUNE GROUP, INC. | Direttore/Membro del Consiglio | 01/12/2021 | - |
Independent Dir/Board Member | 01/12/2021 | - | |
LAVA THERAPEUTICS N.V. | Direttore/Membro del Consiglio | 09/03/2023 | - |
VERA THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 07/06/2024 | - |
Storia della carriera di Christy Oliger
Precedenti posizioni note di Christy Oliger
Società | Posizione | Inizio | Fine |
---|---|---|---|
RAYZEBIO, INC. | Direttore/Membro del Consiglio | 01/08/2023 | 26/02/2024 |
REATA PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 15/04/2021 | 26/09/2023 |
Independent Dir/Board Member | 15/04/2021 | 26/09/2023 | |
SIERRA ONCOLOGY, INC. | Direttore/Membro del Consiglio | 02/06/2021 | 01/07/2022 |
Independent Dir/Board Member | 02/06/2021 | 01/07/2022 | |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/01/2017 | 01/07/2020 |
Formazione di Christy Oliger
University of California, Santa Barbara | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 9 |
Paesi Bassi | 2 |
Posizioni
Director/Board Member | 7 |
Independent Dir/Board Member | 4 |
Corporate Officer/Principal | 1 |
Settori
Health Technology | 9 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 5 |
---|---|
KARYOPHARM THERAPEUTICS INC. | Health Technology |
REPLIMUNE GROUP, INC. | Health Technology |
LAVA THERAPEUTICS N.V. | Health Technology |
RAYZEBIO, INC. | Health Technology |
VERA THERAPEUTICS, INC. | Health Technology |
Aziende private | 3 |
---|---|
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Reata Pharmaceuticals, Inc.
![]() Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX. | Health Technology |
Sierra Oncology, Inc.
![]() Sierra Oncology, Inc. BiotechnologyHealth Technology Sierra Oncology, Inc. was a clinical stage drug development company of therapeutics for the treatment of cancer. The firm focused on advanced targeted therapeutics for the treatment of patients with significant unmet medical needs in hematology and oncology. Its product Momelotinib, a selective and orally-bioavailable JAK1, JAK2 & ACVR1 inhibitor with a differentiated therapeutic profile in myelofibrosis encompassing robust constitutional symptom improvements. The company was founded in May 2003 and is headquartered in San Mateo, CA. | Health Technology |
- Borsa valori
- Insiders
- Christy Oliger
- Esperienza